AI assistant
UNITIL CORP — Director's Dealing 2025
Jan 29, 2025
32380_dirs_2025-01-29_0ecffc23-da9c-474a-b5c6-95d5d8751d4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITIL CORP (UTL)
CIK: 0000755001
Period of Report: 2025-01-28
Reporting Person: Eisfeller Justin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-28 | Common stock, no par value | A | 960 | — | Acquired | 0 | Direct |
| 2025-01-28 | Common stock, no par value | A | 960 | — | Acquired | 16194 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-28 | Contingent grant of common stock | $ | A | 480 | Acquired | Common stock (480) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, no par value | 1250.11 | Indirect |
Footnotes
F1: Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest 25% per year over four years from date of grant. Shares will be valued at current market price on date of vesting.
F2: Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest after three-year performance period based on the attainment of certain performance thresholds of certain performance goals. Shares will be valued at current market price on date of vesting.
F3: Shares are held in trust under the terms of the Unitil Corporation Tax Deferred Savings and Investment Plan.
F4: Shares may be granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Any such shares would be granted after a three-year performance period based on the attainment of certain performance thresholds of certain performance goals. Any such shares would be valued at current market price on date of grant.